chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Feels like a golf ball under the skin; Hot to touch in the injection site; Redness in the injection site; Fluid filled bump in the injection site; Large spot on the right knee that has fluid on the side; Arm soreness; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Large spot on the right knee that has fluid on the side), PAIN IN EXTREMITY (Arm soreness), SKIN SWELLING (Feels like a golf ball under the skin), VACCINATION SITE WARMTH (Hot to touch in the injection site) and VACCINATION SITE ERYTHEMA (Redness in the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PANTOPRAZOLE for Acid reflux (esophageal), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), CHILLS (Chills) and HEADACHE (Headache). On 02-May-2021, the patient experienced JOINT SWELLING (Large spot on the right knee that has fluid on the side), SKIN SWELLING (Feels like a golf ball under the skin), VACCINATION SITE WARMTH (Hot to touch in the injection site), VACCINATION SITE ERYTHEMA (Redness in the injection site) and VACCINATION SITE SWELLING (Fluid filled bump in the injection site). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) at an unspecified dose and frequency. At the time of the report, JOINT SWELLING (Large spot on the right knee that has fluid on the side), PAIN IN EXTREMITY (Arm soreness), SKIN SWELLING (Feels like a golf ball under the skin), VACCINATION SITE WARMTH (Hot to touch in the injection site), VACCINATION SITE ERYTHEMA (Redness in the injection site), VACCINATION SITE SWELLING (Fluid filled bump in the injection site), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Left arm which is swollen; Left arm which is swollen and a little warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Left arm which is swollen) and VACCINATION SITE SWELLING (Left arm which is swollen and a little warm) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Left arm which is swollen) and VACCINATION SITE SWELLING (Left arm which is swollen and a little warm). At the time of the report, VACCINATION SITE WARMTH (Left arm which is swollen) and VACCINATION SITE SWELLING (Left arm which is swollen and a little warm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up received on 15 Jun 2021 included no new information.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Lip swelling, Paraesthesia, Pyrexia
Clinical narrative: Lips feel big; Back of head burning; Tingling torso/ Tingling face; Fever; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Lips feel big), BURNING SENSATION (Back of head burning), PARAESTHESIA (Tingling torso/ Tingling face) and PYREXIA (Fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIP SWELLING (Lips feel big) and BURNING SENSATION (Back of head burning). 01-May-2021, the patient experienced PARAESTHESIA (Tingling torso/ Tingling face) and PYREXIA (Fever). At the time of the report, LIP SWELLING (Lips feel big), BURNING SENSATION (Back of head burning), PARAESTHESIA (Tingling torso/ Tingling face) and PYREXIA (Fever) outcome was unknown.            No treatment information provided.   No concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up information received on 31 May 2021 contains no new information.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Hypoaesthesia, Insomnia, Limb discomfort, Myalgia
Clinical narrative: pain on his left arm that has not went away / feels like it is broken / if you touch him it hurts / in pain all the way down to his leg; can't sleep; can't lift his arm; which is numb; can't stop coughing; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pain on his left arm that has not went away / feels like it is broken / if you touch him it hurts / in pain all the way down to his leg), INSOMNIA (can't sleep), LIMB DISCOMFORT (can't lift his arm), HYPOAESTHESIA (which is numb) and COUGH (can't stop coughing) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV infection. Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (pain on his left arm that has not went away / feels like it is broken / if you touch him it hurts / in pain all the way down to his leg), INSOMNIA (can't sleep), LIMB DISCOMFORT (can't lift his arm), HYPOAESTHESIA (which is numb) and COUGH (can't stop coughing). At the time of the report, MYALGIA (pain on his left arm that has not went away / feels like it is broken / if you touch him it hurts / in pain all the way down to his leg), INSOMNIA (can't sleep), LIMB DISCOMFORT (can't lift his arm), HYPOAESTHESIA (which is numb) and COUGH (can't stop coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD21-084822, US-MODERNATX, INC.-MOD-2021-101638 (E2B Linked Report).; Sender's Comments:  MOD21-084822:Crosslinked case US-MODERNATX, INC.-MOD-2021-101638:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Itching at the injection site, it's about 3 inches long; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site, it's about 3 inches long) in a 60-year-old female patient who received mRNA-1273 (batch no. 046B21A) for COVID-19 vaccination.     Medical history has not been provided.     On 24-Apr-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site, it's about 3 inches long). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site, it's about 3 inches long) outcome was unknown.        The action taken with mRNA-1273 (Unknown) was unknown.       Event treatment has not been specified. Concomitant medications have not been reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest pain, Computerised tomogram, Electrocardiogram, Hypertension
Clinical narrative: chest pain; High blood pressure; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (chest pain) and HYPERTENSION (High blood pressure) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 020B21A) for COVID-19 vaccination.     Medical history was not provided by the reporter.  Concomitant products included LOSARTAN, BACLOFEN, SIMVASTATIN, IRON, FISH OIL and POTASSIUM for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced CHEST PAIN (chest pain) and HYPERTENSION (High blood pressure). The patient was treated with METOPROLOL TARTRATE at a dose of 25 milligram; GLYCERYL TRINITRATE (NITROGLYCERIN) at a dose of 1 UNK and ACETYLSALICYLIC ACID (BABY ASPIRIN) for Chest pain, at a dose of 81 milligram. On 26-Apr-2021, CHEST PAIN (chest pain) and HYPERTENSION (High blood pressure) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Chest X-ray: inconclusive (Inconclusive) Inconclusive. On 26-Apr-2021, Computerised tomogram: inconclusive (Inconclusive) Inconclusive. On 26-Apr-2021, Electrocardiogram: inconclusive (Inconclusive) Inconclusive.         Treatment medications include Metoprolol and Nitroglycerin.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Updated stop date and outcome of the event. On 04-Jun-2021: Follow-up information included non significant information.
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: have received 3rd dose of vaccine; Case is crossed linked with MOD21-084772 Warm Transfer from Moderna Customer care service, case number 00163946.  HCP is returning a missed call from Moderna Medical about an earlier inquiry on how to code a 3rd dose received by a clinical trial patient. They were not sure about the department of Moderna that contacted them. Nurse wants to be contacted back for response as soon as possible.  Best method of contact would be email or phone number. They gave consent to be contacted by Regulatory Authorities
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of hypertension (spike blood pressure) in a male patient, of an unknown age, who received mRNA-1273 for COVID-19 immunization. No medical history reported. Concomitant products included testosterone for an unknown indication. On Feb 16, 2021, patient received the second dose of mRNA-1273, unknown route; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273, intramuscular; 1 dosage form. On Apr 30, 2021, patient experienced hypertension (spike blood pressure). At the time of the report, hypertension (spike blood pressure) outcome: unknown. Diagnostic results: On Apr 30, 2021, blood pressure measurement: 158/84 (high). No treatment medication information provided.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient was given vaccine 19 hours after vial was punctured; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was given vaccine 19 hours after vial was punctured) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was given vaccine 19 hours after vial was punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was given vaccine 19 hours after vial was punctured) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Pharmacist stated vial was punctured at 2:30pm 29-Apr-2021 and patient given dose around 9:30am on 30-Apr-2021. No treatment were reported.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site arm left arm was hurting her; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site arm left arm was hurting her) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (injection site arm left arm was hurting her). At the time of the report, VACCINATION SITE PAIN (injection site arm left arm was hurting her) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not provided by the reporter. Treatment of events was not reported.    This case was linked to MOD-2021-069636 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash macular, Rash pruritic
Clinical narrative: Red rash; rash splotchy; itchy rash; Diffused body rash (rash all over the body); This spontaneous case was reported by a pharmacist and describes the occurrence of RASH ERYTHEMATOUS (Red rash), RASH MACULAR (rash splotchy), RASH PRURITIC (itchy rash) and RASH (Diffused body rash (rash all over the body)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), RASH MACULAR (rash splotchy), RASH PRURITIC (itchy rash) and RASH (Diffused body rash (rash all over the body)). At the time of the report, RASH ERYTHEMATOUS (Red rash), RASH MACULAR (rash splotchy), RASH PRURITIC (itchy rash) and RASH (Diffused body rash (rash all over the body)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Scratch test to patient's skin it turns from pink to light red. No relevant concomitant medications reported Treatment included unspecified antihistamine.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Rash pruritic, Vaccination site discolouration, Vaccination site joint erythema
Clinical narrative: felt her arm begin to be warm; arm was purple; arm was very swollen; arm was painful; arm the size of a plum; arm really red; rash began to spread down; rash was itchy; This spontaneous case was reported by a non-health professional and describes the occurrence of INJECTION SITE WARMTH (felt her arm begin to be warm), VACCINATION SITE DISCOLOURATION (arm was purple), INJECTION SITE SWELLING (arm was very swollen), VACCINATION SITE PAIN (arm was painful) and VACCINATION SITE JOINT ERYTHEMA (arm the size of a plum) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B212A and 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 22-Apr-2021, the patient experienced INJECTION SITE WARMTH (felt her arm begin to be warm), VACCINATION SITE DISCOLOURATION (arm was purple), INJECTION SITE SWELLING (arm was very swollen), VACCINATION SITE PAIN (arm was painful), VACCINATION SITE JOINT ERYTHEMA (arm the size of a plum), VACCINATION SITE JOINT ERYTHEMA (arm really red), VACCINATION SITE RASH (rash began to spread down) and RASH PRURITIC (rash was itchy). At the time of the report, INJECTION SITE WARMTH (felt her arm begin to be warm), VACCINATION SITE DISCOLOURATION (arm was purple), INJECTION SITE SWELLING (arm was very swollen), VACCINATION SITE PAIN (arm was painful), VACCINATION SITE JOINT ERYTHEMA (arm the size of a plum), VACCINATION SITE JOINT ERYTHEMA (arm really red), VACCINATION SITE RASH (rash began to spread down) and RASH PRURITIC (rash was itchy) outcome was unknown.            Concomitant products were not provided/unknown. Treatment medication were not reported/unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: felt her arm begin to be warm; arm was purple; arm was very swollen; arm was painful; arm the size of a plum; arm really red; rash began to spread down; rash was itchy; This spontaneous case was reported by a non-health professional and describes the occurrence of INJECTION SITE WARMTH (felt her arm begin to be warm), VACCINATION SITE DISCOLOURATION (arm was purple), INJECTION SITE SWELLING (arm was very swollen), VACCINATION SITE PAIN (arm was painful) and VACCINATION SITE JOINT ERYTHEMA (arm the size of a plum) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B212A and 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 22-Apr-2021, the patient experienced INJECTION SITE WARMTH (felt her arm begin to be warm), VACCINATION SITE DISCOLOURATION (arm was purple), INJECTION SITE SWELLING (arm was very swollen), VACCINATION SITE PAIN (arm was painful), VACCINATION SITE JOINT ERYTHEMA (arm the size of a plum), VACCINATION SITE JOINT ERYTHEMA (arm really red), VACCINATION SITE RASH (rash began to spread down) and RASH PRURITIC (rash was itchy). At the time of the report, INJECTION SITE WARMTH (felt her arm begin to be warm), VACCINATION SITE DISCOLOURATION (arm was purple), INJECTION SITE SWELLING (arm was very swollen), VACCINATION SITE PAIN (arm was painful), VACCINATION SITE JOINT ERYTHEMA (arm the size of a plum), VACCINATION SITE JOINT ERYTHEMA (arm really red), VACCINATION SITE RASH (rash began to spread down) and RASH PRURITIC (rash was itchy) outcome was unknown.            Concomitant products were not provided/unknown. Treatment medication were not reported/unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Some pain in the arm where the vaccine was injected; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Some pain in the arm where the vaccine was injected) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE PAIN (Some pain in the arm where the vaccine was injected). At the time of the report, VACCINATION SITE PAIN (Some pain in the arm where the vaccine was injected) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.   No concomitant medications were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: losing her hair/I'll practically be bald headed in a little bit; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (losing her hair/I'll practically be bald headed in a little bit) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 12-Nov-2020. Concomitant products included COLECALCIFEROL (VITAMIN D3) for Vitamin D deficiency, TORSEMIDE, LISINOPRIL, AMLODIPINE BESYLATE and ATORVASTATIN for an unknown indication.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (losing her hair/I'll practically be bald headed in a little bit). At the time of the report, ALOPECIA (losing her hair/I'll practically be bald headed in a little bit) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itchy arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy arm) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PRURITUS (itchy arm). At the time of the report, PRURITUS (itchy arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.   Reporter did not allow further contact
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product use issue
Clinical narrative: 17 years old recieved vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT USE ISSUE (17 years old recieved vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced PRODUCT USE ISSUE (17 years old recieved vaccine). On 30-Apr-2021, PRODUCT USE ISSUE (17 years old recieved vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication was provided  Treatment medication was not provided
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Malaise
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (I just fell over and slept a long time) and MALAISE (felt like if I touched something I would break in pieces) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M#17B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included ATORVASTATIN for Cholesterol, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced HYPERSOMNIA (I just fell over and slept a long time) and MALAISE (felt like if I touched something I would break in pieces). The patient was treated with IBUPROFEN ongoing since an unknown date for Pain, at a dose of 1 dosage form as required and PARACETAMOL (8HR ARTHRITIS PAIN RELIEF) ongoing since an unknown date at a dose of 650 milligram as required. At the time of the report, HYPERSOMNIA (I just fell over and slept a long time) and MALAISE (felt like if I touched something I would break in pieces) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-100860 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: "COVID Arm" rash/rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of RASH ("COVID Arm" rash/rash all over body) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ("COVID Arm" rash/rash all over body). At the time of the report, RASH ("COVID Arm" rash/rash all over body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. No concomitant medications were reported.   On an unknown date, approximately three weeks after receiving the first dose of the Moderna COVID-19 vaccine, the patient experienced COVID arm rash that had spread all over the body.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches) and PYREXIA (fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced PAIN (body aches) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PAIN (body aches) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration interrupted, Product availability issue
Clinical narrative: Extended interval in vaccine schedule; Extended interval in vaccine schedule; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (Extended interval in vaccine schedule) and PRODUCT AVAILABILITY ISSUE (Extended interval in vaccine schedule) in a 23-year-old male patient who received mRNA-1273 (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Extended interval in vaccine schedule) and PRODUCT AVAILABILITY ISSUE (Extended interval in vaccine schedule). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (Extended interval in vaccine schedule) and PRODUCT AVAILABILITY ISSUE (Extended interval in vaccine schedule) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Lymphadenopathy, Myalgia, Pain
Clinical narrative: Red; Hurt; lymph nodes swelling under breast in the same side of the injection; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever). At the time of the report, ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Red; Hurt; lymph nodes swelling under breast in the same side of the injection; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever). At the time of the report, ERYTHEMA (Red), PAIN (Hurt), LYMPHADENOPATHY (lymph nodes swelling under breast in the same side of the injection), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Headache, Mobility decreased
Clinical narrative: lower back to ankle pain; could not get out of her bed, can not site down too long; Neck spasm; pain all over (Pain scale 9); Fever; Headache; Chills; lower back to ankle pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back to ankle pain), MOBILITY DECREASED (could not get out of her bed, can not site down too long), MUSCLE SPASMS (Neck spasm), PAIN (pain all over (Pain scale 9)) and PYREXIA (Fever) in a 62-year-old female patient who received mRNA-1273 for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sciatica, Asthma, Heart failure and Neuropathy. Concurrent medical conditions included Sclerosis multiple and COPD.    On an unknown date, the patient received dose of mRNA-1273 (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced BACK PAIN (lower back to ankle pain), MOBILITY DECREASED (could not get out of her bed, can not site down too long), MUSCLE SPASMS (Neck spasm), PAIN (pain all over (Pain scale 9)), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (lower back to ankle pain). At the time of the report, BACK PAIN (lower back to ankle pain), MOBILITY DECREASED (could not get out of her bed, can not site down too long), MUSCLE SPASMS (Neck spasm), PAIN (pain all over (Pain scale 9)), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (lower back to ankle pain) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No treatment information was provided.  No concomitant product was reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pain, Pyrexia
Clinical narrative: lower back to ankle pain; could not get out of her bed, can not site down too long; Neck spasm; pain all over (Pain scale 9); Fever; Headache; Chills; lower back to ankle pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back to ankle pain), MOBILITY DECREASED (could not get out of her bed, can not site down too long), MUSCLE SPASMS (Neck spasm), PAIN (pain all over (Pain scale 9)) and PYREXIA (Fever) in a 62-year-old female patient who received mRNA-1273 for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sciatica, Asthma, Heart failure and Neuropathy. Concurrent medical conditions included Sclerosis multiple and COPD.    On an unknown date, the patient received dose of mRNA-1273 (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced BACK PAIN (lower back to ankle pain), MOBILITY DECREASED (could not get out of her bed, can not site down too long), MUSCLE SPASMS (Neck spasm), PAIN (pain all over (Pain scale 9)), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (lower back to ankle pain). At the time of the report, BACK PAIN (lower back to ankle pain), MOBILITY DECREASED (could not get out of her bed, can not site down too long), MUSCLE SPASMS (Neck spasm), PAIN (pain all over (Pain scale 9)), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (lower back to ankle pain) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No treatment information was provided.  No concomitant product was reported.
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching, Vaccination site pain
Clinical narrative: muscle trembling; mild pain at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (muscle trembling) and VACCINATION SITE PAIN (mild pain at the site of the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     The patient's past medical history included Cervical dystonia.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced MUSCLE TWITCHING (muscle trembling) and VACCINATION SITE PAIN (mild pain at the site of the injection). At the time of the report, MUSCLE TWITCHING (muscle trembling) and VACCINATION SITE PAIN (mild pain at the site of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment related information was reported.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dry mouth, Erythema, Feeling hot, Pain in extremity
Clinical narrative: Her mouth is dry; Her arm is red; itchy/She just wants to hold it and itch it; feels warm; Arm is really sore; She was coughing a lot; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Her mouth is dry), PAIN IN EXTREMITY (Arm is really sore), COUGH (She was coughing a lot), ERYTHEMA (Her arm is red) and PRURITUS (itchy/She just wants to hold it and itch it) in a female patient who received mRNA-1273 for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm is really sore) and COUGH (She was coughing a lot). On an unknown date, the patient experienced DRY MOUTH (Her mouth is dry), ERYTHEMA (Her arm is red), PRURITUS (itchy/She just wants to hold it and itch it) and FEELING HOT (feels warm). At the time of the report, DRY MOUTH (Her mouth is dry), PAIN IN EXTREMITY (Arm is really sore), COUGH (She was coughing a lot), ERYTHEMA (Her arm is red), PRURITUS (itchy/She just wants to hold it and itch it) and FEELING HOT (feels warm) outcome was unknown.        The action taken with mRNA-1273 (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Her mouth is dry; Her arm is red; itchy/She just wants to hold it and itch it; feels warm; Arm is really sore; She was coughing a lot; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Her mouth is dry), PAIN IN EXTREMITY (Arm is really sore), COUGH (She was coughing a lot), ERYTHEMA (Her arm is red) and PRURITUS (itchy/She just wants to hold it and itch it) in a female patient who received mRNA-1273 for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm is really sore) and COUGH (She was coughing a lot). On an unknown date, the patient experienced DRY MOUTH (Her mouth is dry), ERYTHEMA (Her arm is red), PRURITUS (itchy/She just wants to hold it and itch it) and FEELING HOT (feels warm). At the time of the report, DRY MOUTH (Her mouth is dry), PAIN IN EXTREMITY (Arm is really sore), COUGH (She was coughing a lot), ERYTHEMA (Her arm is red), PRURITUS (itchy/She just wants to hold it and itch it) and FEELING HOT (feels warm) outcome was unknown.        The action taken with mRNA-1273 (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: Stabbing arm pain/collar bone down to fingers.; rash at injection site area; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Apr-2021 and was forwarded to Moderna on 01-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Stabbing arm pain/collar bone down to fingers.) and VACCINATION SITE RASH (rash at injection site area) in a 43-year-old female patient who received mRNA-1273 (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PAIN IN EXTREMITY (Stabbing arm pain/collar bone down to fingers.) and VACCINATION SITE RASH (rash at injection site area). At the time of the report, PAIN IN EXTREMITY (Stabbing arm pain/collar bone down to fingers.) and VACCINATION SITE RASH (rash at injection site area) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-May-2021 and was forwarded to Moderna on 02-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication listed.  No treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Gait disturbance
Clinical narrative: Grabbing things to steady herself; Lightheadness; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Grabbing things to steady herself), DIZZINESS (Lightheadness) and DIZZINESS (Dizziness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced GAIT DISTURBANCE (Grabbing things to steady herself), DIZZINESS (Lightheadness) and DIZZINESS (Dizziness). At the time of the report, GAIT DISTURBANCE (Grabbing things to steady herself), DIZZINESS (Lightheadness) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were reported. No Treatment Medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Flatulence
Clinical narrative: diarrhea; gas; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and FLATULENCE (gas) in a 71-year-old female patient who received mRNA-1273 for COVID-19 immunisation.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and FLATULENCE (gas). At the time of the report, DIARRHOEA (diarrhea) and FLATULENCE (gas) had not resolved.        The action taken with mRNA-1273 (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information for the events was provided.   Reporter did not allow further contact
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Eye irritation, Migraine, Myalgia
Clinical narrative: Sore arm; Fever; Severe nausea; Chills; Body ache; Burning eyes; Dizzy; Migraine type headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Burning eyes), DIZZINESS (Dizzy), MIGRAINE (Migraine type headache), PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced EYE IRRITATION (Burning eyes), DIZZINESS (Dizzy), MIGRAINE (Migraine type headache), PYREXIA (Fever), NAUSEA (Severe nausea), CHILLS (Chills) and MYALGIA (Body ache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, EYE IRRITATION (Burning eyes), DIZZINESS (Dizzy), MIGRAINE (Migraine type headache), PYREXIA (Fever), NAUSEA (Severe nausea), CHILLS (Chills) and MYALGIA (Body ache) had resolved and PAIN IN EXTREMITY (Sore arm) had not resolved.            No relevant concomitant medications were reported.  No treatment information was reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Fever; Severe nausea; Chills; Body ache; Burning eyes; Dizzy; Migraine type headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Burning eyes), DIZZINESS (Dizzy), MIGRAINE (Migraine type headache), PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced EYE IRRITATION (Burning eyes), DIZZINESS (Dizzy), MIGRAINE (Migraine type headache), PYREXIA (Fever), NAUSEA (Severe nausea), CHILLS (Chills) and MYALGIA (Body ache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, EYE IRRITATION (Burning eyes), DIZZINESS (Dizzy), MIGRAINE (Migraine type headache), PYREXIA (Fever), NAUSEA (Severe nausea), CHILLS (Chills) and MYALGIA (Body ache) had resolved and PAIN IN EXTREMITY (Sore arm) had not resolved.            No relevant concomitant medications were reported.  No treatment information was reported.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Peripheral swelling
Clinical narrative: swollen middle finger; inflammed middle finger; This spontaneous case was reported by a physician and describes the occurrence of PERIPHERAL SWELLING (swollen middle finger) and INFLAMMATION (inflammed middle finger) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 036B21A) for COVID-19 vaccination.     Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) and HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen middle finger) and INFLAMMATION (inflammed middle finger). The patient was treated with IBUPROFEN at an unspecified dose and frequency; SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) at an unspecified dose and frequency and CEFALEXIN (KEFLEX [CEFALEXIN]) at a dose of for 10 days. At the time of the report, PERIPHERAL SWELLING (swollen middle finger) and INFLAMMATION (inflammed middle finger) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication includes Hot-cold Compress,; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.